6192 — Lumax International Balance Sheet
0.000.00%
- TWD8.89bn
- TWD4.90bn
- TWD7.83bn
- 90
- 80
- 55
- 90
Annual balance sheet for Lumax International, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2,973 | 3,563 | 3,496 | 3,795 | 4,017 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,547 | 1,809 | 1,769 | 2,029 | 2,296 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 6,364 | 7,533 | 8,402 | 9,292 | 9,658 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,132 | 1,070 | 1,229 | 1,293 | 1,498 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 8,026 | 9,115 | 9,901 | 10,892 | 11,436 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2,446 | 3,033 | 3,427 | 4,065 | 3,991 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 2,804 | 3,420 | 3,817 | 4,428 | 4,355 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 5,222 | 5,695 | 6,084 | 6,464 | 7,081 |
Total Liabilities & Shareholders' Equity | 8,026 | 9,115 | 9,901 | 10,892 | 11,436 |
Total Common Shares Outstanding |